🚀 Tomorrow's the day! Get ready to dive deep into VI-RADS with Prof. Valeria Panebianco & Dr. Martina Pecoraro. 📅 Join us on May 21st at 18:00 for an enlightening webinar packed with expertise and innovation. Secure your spot now!

Excited to announce the new format of popular 12th ESUR Prostate MRI course June 27-29 in Zeist NL (>250 signed-up already)! Featuring short talks by experts, and full-day of MDT sessions + case-based review + hands-on teaching. Register: esur.org/registration-m…

Please Retweet!

Great and clear presentation of #PIQUAL 2.0 by Francesco Giganti today, thanks for simplifying, this will definitely go into a structured report. We'll probably just use Optimal/Acceptable/Inadequate instead of numbers as a result so it doesn't get confusing.

Headline message from Andreas Røder - PSA screening trials show a 0.5% absolute risk reduction over ~18-22 years

Is this worth it?

#ipmasterclass24

Radiologové, přijďte v sobotu 27.4.2024 na Masarykův onkologický ústav Brno MOÚ workshop - MR prostaty pro pokročilé. Probereme PI-RADS, PRECISE, PI-RR a další. Přednášet a diskutovat s vámi budou radiologové, urolog i patolog. Každý bude mít svou diagnostickou stanici. t.ly/q3Tih

“Blind deconvolution decreases requirements on temporal resolution of DCE-MRI: Application to 2nd generation pharmacokinetic modeling.”
Next step towards a more robust quantitative #DCE -MRI methodology. authors.elsevier.com/c/1iqBI,GdM5rV…

Another wonderful case for our Advanced prostate MRI course at MMCI Masarykův onkologický ústav Brno Hint: Read the patient summary.

🚨A new plain English summary of IP1- #Prostagram just published in NIHR evidence

📰Have a read for a nice summary of the multiple publications from trial

🔓Explores how the data was useful in informing design of #Transform trial

evidence.nihr.ac.uk/alert/mri-scre…

TL;DR version: MRI changed how we found prostate cancer, but we didn't update our pathology or treatment guidelines

Is digital rectal exam (DRE) a good prostate cancer screening test? We know that fear of DRE is one of the biggest barriers to men talking to their GP about prostate concerns. Read our The British Journal of General Practice paper on why DRE need not be a routine screening test: bit.ly/3wDBZrF

It was a great honour to be on the same stage with Vibeke Løgager CORNUD François Martina Pecoraro and the others. Great session. Thanks.

It's time to define optimal PI-RADS cut-off according to population characteristics Anwar Padhani ESUR Junior Network myesr #MRI #ProstateCancer #screening

Excellent review on PSA-based screening. However detection still depends on PSA above 3. #Prostagram and other studies show a substantial proportion of cancers in men with PSA 1-3. We need data on these too.

V nové epizodě podcastu Co vy na to, doktore? se věnujeme screeningu rakoviny prostaty. Co se za tímto pojmem skrývá a proč není potřeba se ho obávat? To se dozvíte v rozhovoru s primářem urologického oddělení #MOÚ doc. MUDr. Michalem Staníkem, PhD.
👉open.spotify.com/episode/4nUqjy…

All studies point to the same direction and are reassuring.
MRI invisible lesions seem less aggressive that MRI visible lesions. We question the value of systematic biopsies in routine prostate cancer diagnostic pathway utilizing MRI. 2/5

1/2 V sobotu se konal v posluchárně RECAMO kurz Magnetické rezonance prostaty, na který přijelo 25 radiologů z celé ČR. Ti si vyslechli přednášky od radiologů z #MOÚ MUDr. Křístka, MUDr. Standary a MUDr. Pacala a paní primářky MUDr. Slámové z Nemocnice Nové Město na Moravě.

doi.org/10.1186/s13244…
1. Extraprostatic findings (EPFs) are common in prostate MRI
2. EPFs are underreported in 70%
3. 2.4% are clinically relevant

Sensitivity is also lacking. About half of ISUP2+ pts PSA below 3ng/ml. See #Prostagram study.

🌟Exiting to see #Prostagram getting a full page feature in todays paper

👏 Thanks @f1professor for sharing your personal cancer story & Stephen Fry for recruiting so well

👉Article at:
dailymail.co.uk/health/article…

Hashim U. Ahmed Heminder Kaur Sokhi Surgery and Cancer Imperial Urology

V tuzemsku se ve zdravotnictví čím dál častěji prosazují moderní technologie, jako jsou roboti a umělá inteligence. Pomáhají v současnosti například v diagnostice rakoviny. Lékaři je využívají hlavně tehdy, když nádory rostou na špatně dostupných místech.